BIORETEC OY (F:0TN) — Market Cap & Net Worth
Market Cap & Net Worth: BIORETEC OY (0TN)
BIORETEC OY (F:0TN) has a market capitalization of $16.10 Million (€13.77 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25876 globally and #2218 in its home market, demonstrating a 22.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIORETEC OY's stock price €0.03 by its total outstanding shares 1341785963 (1.34 Billion). Also see 0TN total asset value for a full breakdown of the balance sheet.
BIORETEC OY Market Cap History: 2021 to 2026
BIORETEC OY's market capitalization history from 2021 to 2026. Data shows change from $4.36 Billion to $40.47 Million (-61.75% CAGR). Also see BIORETEC OY (0TN) cash flow conversion for how efficiently the company converts equity into cash flow.
BIORETEC OY Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIORETEC OY's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 0TN live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
260.14x
BIORETEC OY's market cap is 260.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $4.36 Billion | $2.00 Million | -$6.02 Million | 2177.31x | N/A |
| 2022 | $2.09 Billion | $2.94 Million | -$2.42 Million | 709.18x | N/A |
| 2023 | $3.61 Billion | $3.91 Million | -$3.79 Million | 923.66x | N/A |
| 2024 | $3.51 Billion | $4.54 Million | -$4.61 Million | 773.36x | N/A |
| 2025 | $916.11 Million | $3.52 Million | -$9.48 Million | 260.14x | N/A |
Competitor Companies of 0TN by Market Capitalization
Companies near BIORETEC OY in the global market cap rankings as of September 19, 2026. Review 0TN tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to BIORETEC OY by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
BIORETEC OY Historical Marketcap From 2021 to 2026
Between 2021 and today, BIORETEC OY's market cap moved from $4.36 Billion to $ 40.47 Million, with a yearly change of -61.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €40.47 Million | -95.58% |
| 2025 | €916.11 Million | -73.93% |
| 2024 | €3.51 Billion | -2.61% |
| 2023 | €3.61 Billion | +72.93% |
| 2022 | €2.09 Billion | -52.16% |
| 2021 | €4.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of BIORETEC OY was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.10 Million USD |
| MoneyControl | $16.10 Million USD |
| MarketWatch | $16.10 Million USD |
| marketcap.company | $16.10 Million USD |
| Reuters | $16.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more